213 related articles for article (PubMed ID: 19422376)
1. Beta 1- and beta 2-adrenoceptor polymorphisms and cardiovascular diseases.
Leineweber K; Heusch G
Br J Pharmacol; 2009 Sep; 158(1):61-9. PubMed ID: 19422376
[TBL] [Abstract][Full Text] [Related]
2. Beta1- and beta2-adrenoceptor polymorphisms and cardiovascular diseases.
Brodde OE
Fundam Clin Pharmacol; 2008 Apr; 22(2):107-25. PubMed ID: 18353108
[TBL] [Abstract][Full Text] [Related]
3. Beta-1 and beta-2 adrenoceptor polymorphisms: functional importance, impact on cardiovascular diseases and drug responses.
Brodde OE
Pharmacol Ther; 2008 Jan; 117(1):1-29. PubMed ID: 17916379
[TBL] [Abstract][Full Text] [Related]
4. Beta-adrenergic receptor polymorphism in human cardiovascular disease.
Leineweber K
Ann Med; 2004; 36 Suppl 1():64-9. PubMed ID: 15176426
[TBL] [Abstract][Full Text] [Related]
5. Association of beta-adrenoceptor polymorphisms with cardiac autonomic modulation in Japanese males.
Matsunaga T; Yasuda K; Adachi T; Gu N; Yamamura T; Moritani T; Tsujimoto G; Tsuda K
Am Heart J; 2007 Oct; 154(4):759-66. PubMed ID: 17893006
[TBL] [Abstract][Full Text] [Related]
6. The Arg16Gly-β(2)-adrenoceptor single nucleotide polymorphism: exercise capacity and survival in patients with end-stage heart failure.
Leineweber K; Frey UH; Tenderich G; Toliat MR; Zittermann A; Nürnberg P; Körfer R; Siffert W; Heusch G
Naunyn Schmiedebergs Arch Pharmacol; 2010 Oct; 382(4):357-65. PubMed ID: 20803192
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in beta-adrenergic receptor genes in the acquired long QT syndrome.
Kanki H; Yang P; Xie HG; Kim RB; George AL; Roden DM
J Cardiovasc Electrophysiol; 2002 Mar; 13(3):252-6. PubMed ID: 11942593
[TBL] [Abstract][Full Text] [Related]
8. [Interactions between beta1 and beta2 adrenergic receptor polymorphisms as risk factors for chronic heart failure].
Moraga F; Troncoso R; Mellado R; Díaz-Araya G; Vukasovic JL; Greig D; Perez O; García L; Roldán J; Ocaranza MP; Jali J; Chiong M; Castro P
Rev Med Chil; 2008 Nov; 136(11):1371-80. PubMed ID: 19301767
[TBL] [Abstract][Full Text] [Related]
9. Beta2-adrenoceptor polymorphisms: relation between in vitro and in vivo phenotypes.
Leineweber K; Brodde OE
Life Sci; 2004 Apr; 74(23):2803-14. PubMed ID: 15072081
[TBL] [Abstract][Full Text] [Related]
10. Beta-adrenoceptor polymorphisms.
Leineweber K; Büscher R; Bruck H; Brodde OE
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jan; 369(1):1-22. PubMed ID: 14647973
[TBL] [Abstract][Full Text] [Related]
11. Association of beta-1 and beta-2 adrenergic receptor gene polymorphisms with myocardial infarction.
Yilmaz A; Kaya MG; Merdanoglu U; Ergun MA; Cengel A; Menevse S
J Clin Lab Anal; 2009; 23(4):237-43. PubMed ID: 19623647
[TBL] [Abstract][Full Text] [Related]
12. Human beta2-adrenergic receptor gene haplotypes and venodilation in vivo.
Bruck H; Leineweber K; Park J; Weber M; Heusch G; Philipp T; Brodde OE
Clin Pharmacol Ther; 2005 Sep; 78(3):232-8. PubMed ID: 16153394
[TBL] [Abstract][Full Text] [Related]
13. Beta2-adrenoceptor gene polymorphisms.
Brodde OE; Leineweber K
Pharmacogenet Genomics; 2005 May; 15(5):267-75. PubMed ID: 15864127
[TBL] [Abstract][Full Text] [Related]
14. Beta2-adrenergic receptor polymorphisms and treatment-induced regression of left ventricular hypertrophy in hypertension.
Iaccarino G; Izzo R; Trimarco V; Cipolletta E; Lanni F; Sorriento D; Iovino GL; Rozza F; De Luca N; Priante O; Di Renzo G; Trimarco B
Clin Pharmacol Ther; 2006 Dec; 80(6):633-45. PubMed ID: 17178264
[TBL] [Abstract][Full Text] [Related]
15. Is there a role of the Thr164Ile-beta(2)-adrenoceptor polymorphism for the outcome of chronic heart failure?
Leineweber K; Tenderich G; Wolf C; Wagner S; Zittermann A; Elter-Schulz M; Moog R; Müller N; Jakob HG; Körfer R; Philipp T; Heusch G; Brodde OE
Basic Res Cardiol; 2006 Nov; 101(6):479-84. PubMed ID: 16783489
[TBL] [Abstract][Full Text] [Related]
16. Beta1- and beta2-adrenergic receptor polymorphisms affect susceptibility to idiopathic dilated cardiomyopathy.
Forleo C; Sorrentino S; Guida P; Romito R; De Tommasi E; Iacoviello M; Pitzalis M
J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):589-95. PubMed ID: 17667029
[TBL] [Abstract][Full Text] [Related]
17. Adrenergic beta1 receptor polymorphism (Ser49Gly) is associated with obesity in type II diabetic patients.
Nonen S; Yamamoto I; Liu J; Maeda M; Motomura T; Igarashi T; Fujio Y; Azuma J
Biol Pharm Bull; 2008 Feb; 31(2):295-8. PubMed ID: 18239290
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of the beta(2)-adrenergic receptor determine exercise capacity in patients with heart failure.
Wagoner LE; Craft LL; Singh B; Suresh DP; Zengel PW; McGuire N; Abraham WT; Chenier TC; Dorn GW; Liggett SB
Circ Res; 2000 Apr; 86(8):834-40. PubMed ID: 10785504
[TBL] [Abstract][Full Text] [Related]
19. In patients chronically treated with metoprolol, the demand of inotropic catecholamine support after coronary artery bypass grafting is determined by the Arg389Gly-beta 1-adrenoceptor polymorphism.
Leineweber K; Bogedain P; Wolf C; Wagner S; Weber M; Jakob HG; Heusch G; Philipp T; Brodde OE
Naunyn Schmiedebergs Arch Pharmacol; 2007 Jul; 375(5):303-9. PubMed ID: 17541557
[TBL] [Abstract][Full Text] [Related]
20. Influence of beta-2 adrenergic receptor gene polymorphism on the hemodynamic response to propranolol in patients with cirrhosis.
Turnes J; Hernández-Guerra M; Abraldes JG; Bellot P; Oliva R; García-Pagán JC; Bosch J
Hepatology; 2006 Jan; 43(1):34-41. PubMed ID: 16374847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
